Since activating EGFR and Ras mutations are rare in breast cancer, activation of Ras proteins in TNBC may be dependent on mostly wild type oncogenic receptor tyrosine kinases via RasGEFs such as SOS1 and GRF2. This evidence concerns the gene SOS1 and breast carcinoma.